These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36613613)

  • 1. Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option.
    Maloberti A; Fabbri S; Colombo V; Gualini E; Monticelli M; Daus F; Busti A; Galasso M; De Censi L; Algeri M; Merlini PA; Giannattasio C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
    Hung MY; Tsimikas S
    Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a): When to Measure and How to Treat?
    Rhainds D; Brodeur MR; Tardif JC
    Curr Atheroscler Rep; 2021 Jul; 23(9):51. PubMed ID: 34235598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
    Nordestgaard BG; Langsted A
    J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Kronenberg F; Mora S; Stroes ESG; Ference BA; Arsenault BJ; Berglund L; Dweck MR; Koschinsky M; Lambert G; Mach F; McNeal CJ; Moriarty PM; Natarajan P; Nordestgaard BG; Parhofer KG; Virani SS; von Eckardstein A; Watts GF; Stock JK; Ray KK; Tokgözoğlu LS; Catapano AL
    Eur Heart J; 2022 Oct; 43(39):3925-3946. PubMed ID: 36036785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.
    Yeang C; Wilkinson MJ; Tsimikas S
    Curr Opin Cardiol; 2016 Jul; 31(4):440-50. PubMed ID: 27205885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in clinical practice: A guide for the clinician.
    Krittanawong C; Maitra NS; El-Sherbini AH; Shah N; Lavie CJ; Shapiro MD; Virani SS
    Prog Cardiovasc Dis; 2023; 79():28-36. PubMed ID: 37516261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein(a): relationships with atherosclerosis and valvular heart disease, and emerging therapies].
    Abrignani MG; Maloberti A; Di Fusco SA; Lucà F; Cesaro A; Acerbo V; Fabbri S; Di Matteo I; Amico AF; Temporelli PL; Riccio C; Colivicchi F; Grimaldi M; Gabrielli D; Oliva F
    G Ital Cardiol (Rome); 2024 Feb; 25(2):76-87. PubMed ID: 38270363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lp(a) - an overlooked risk factor.
    Laffin LJ; Nissen SE
    Trends Cardiovasc Med; 2024 Apr; 34(3):193-199. PubMed ID: 36681362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Frontiers in Lp(a)-Targeted Therapies.
    Borrelli MJ; Youssef A; Boffa MB; Koschinsky ML
    Trends Pharmacol Sci; 2019 Mar; 40(3):212-225. PubMed ID: 30732864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.
    Di Costanzo A; Indolfi C; Franzone A; Esposito G; Spaccarotella CAM
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis.
    Thanassoulis G
    J Lipid Res; 2016 Jun; 57(6):917-24. PubMed ID: 26685327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.
    Smith JG; Luk K; Schulz CA; Engert JC; Do R; Hindy G; Rukh G; Dufresne L; Almgren P; Owens DS; Harris TB; Peloso GM; Kerr KF; Wong Q; Smith AV; Budoff MJ; Rotter JI; Cupples LA; Rich S; Kathiresan S; Orho-Melander M; Gudnason V; O'Donnell CJ; Post WS; Thanassoulis G;
    JAMA; 2014 Nov; 312(17):1764-71. PubMed ID: 25344734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective.
    Arsenault BJ; Kamstrup PR
    Atherosclerosis; 2022 May; 349():7-16. PubMed ID: 35606078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a): Role in atherosclerosis and new treatment options.
    Tomic Naglic D; Manojlovic M; Pejakovic S; Stepanovic K; Prodanovic Simeunovic J
    Biomol Biomed; 2023 Jul; 23(4):575-583. PubMed ID: 37183706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study.
    Šuran D; Blažun Vošner H; Završnik J; Kokol P; Sinkovič A; Kanič V; Kokol M; Naji F; Završnik T
    Front Public Health; 2022; 10():923797. PubMed ID: 35865239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein a - Lp(a).
    Ghose T
    Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S117-S120. PubMed ID: 38160790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?
    Nicholls SJ; Bubb KJ
    Curr Cardiol Rep; 2021 Jul; 23(8):97. PubMed ID: 34196823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a): Expanding our knowledge of aortic valve narrowing.
    Youssef A; Clark JR; Koschinsky ML; Boffa MB
    Trends Cardiovasc Med; 2021 Jul; 31(5):305-311. PubMed ID: 32525013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.